secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001493152-24-015330
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis receives Nasdaq delisting notice after restatement reveals stockholders' deficit of $15.4M
--------------------------------------------------------------------------------

- On April 17, 2024, Nasdaq notified Orgenesis it no longer meets the minimum $2.5M stockholders' equity for continued listing (Rule 5550(b)(1)) after restatement.
- A prior second 180-day compliance period was based on reported equity of $12.4M; the restated Sept 30, 2023 period now shows a deficit of $(15.4M).
- Nasdaq stated it cannot accept a compliance plan; Orgenesis plans to timely request a hearing before the Panel, which stays delisting pending the outcome.
- Common stock will remain listed and trading on Nasdaq at least until the hearing process concludes.
- There is no assurance the company will regain compliance or maintain its Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224015330/0001493152-24-015330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224015330/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer